AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,314,000 | +55.0% | 67,157 | -24.8% | 0.00% | +100.0% |
Q2 2020 | $1,493,000 | +33.3% | 89,327 | +15.0% | 0.00% | 0.0% |
Q1 2020 | $1,120,000 | -51.4% | 77,674 | +12.8% | 0.00% | -50.0% |
Q4 2019 | $2,304,000 | +72.2% | 68,831 | +7.7% | 0.00% | +100.0% |
Q3 2019 | $1,338,000 | +1.3% | 63,890 | +0.7% | 0.00% | 0.0% |
Q2 2019 | $1,321,000 | +2.9% | 63,428 | +10.4% | 0.00% | 0.0% |
Q1 2019 | $1,284,000 | -7.4% | 57,453 | -0.9% | 0.00% | -33.3% |
Q4 2018 | $1,386,000 | +30.1% | 57,947 | +48.5% | 0.00% | +50.0% |
Q3 2018 | $1,065,000 | -5.1% | 39,031 | -6.5% | 0.00% | 0.0% |
Q2 2018 | $1,122,000 | +5.6% | 41,731 | +25.0% | 0.00% | 0.0% |
Q1 2018 | $1,063,000 | -17.0% | 33,383 | -1.4% | 0.00% | -33.3% |
Q4 2017 | $1,281,000 | +28.7% | 33,863 | -15.7% | 0.00% | +50.0% |
Q3 2017 | $995,000 | +22.4% | 40,150 | +1.5% | 0.00% | 0.0% |
Q2 2017 | $813,000 | +26.2% | 39,560 | +33.5% | 0.00% | 0.0% |
Q1 2017 | $644,000 | +9.9% | 29,632 | +3.5% | 0.00% | +100.0% |
Q4 2016 | $586,000 | +52.6% | 28,637 | +11.8% | 0.00% | 0.0% |
Q3 2016 | $384,000 | +67.7% | 25,607 | +20.8% | 0.00% | 0.0% |
Q2 2016 | $229,000 | +57.9% | 21,200 | +98.5% | 0.00% | – |
Q1 2016 | $145,000 | – | 10,680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |